Total Payments
$4,228
2024 Payments
$541.97
Companies
27
Transactions
221
Medicare Patients
3,548
Medicare Billing
$404,719
Payment Breakdown by Category
Food & Beverage$4,220 (99.8%)
Education$7.86 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,220 | 220 | 99.8% |
| Education | $7.86 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,027 | 54 | $0 (2024) |
| Gilead Sciences, Inc. | $467.79 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $430.23 | 18 | $0 (2024) |
| PFIZER INC. | $398.40 | 21 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $388.33 | 18 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $367.84 | 21 | $0 (2024) |
| Braintree Laboratories, Inc. | $173.46 | 9 | $0 (2022) |
| Allergan Inc. | $108.69 | 6 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $107.62 | 6 | $0 (2018) |
| INTERCEPT PHARMACEUTICALS, INC. | $66.97 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $541.97 | 21 | ABBVIE INC. ($153.95) |
| 2023 | $670.52 | 30 | AbbVie Inc. ($207.56) |
| 2022 | $673.18 | 32 | ABBVIE INC. ($179.73) |
| 2021 | $196.52 | 9 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($39.92) |
| 2020 | $106.43 | 6 | AbbVie Inc. ($66.74) |
| 2019 | $605.62 | 35 | PFIZER INC. ($115.92) |
| 2018 | $756.08 | 45 | AbbVie, Inc. ($122.63) |
| 2017 | $677.42 | 43 | AbbVie, Inc. ($192.31) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $29.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/20/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Immunology | ||||||
| 09/07/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 06/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/31/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: Immunology | ||||||
| 05/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $34.03 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: Gastroenterology | ||||||
| 05/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Gastroenterology | ||||||
| 04/25/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $27.14 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/15/2024 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: IMMUNOLOGY | ||||||
| 03/01/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: Gastroenterology | ||||||
| 02/16/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: Immunology | ||||||
| 02/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.88 | General |
| 01/27/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 01/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: IMMUNOLOGY | ||||||
| 01/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/17/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/10/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2023 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/28/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 862 | 927 | $870,631 | $103,708 |
| 2022 | 15 | 971 | 1,036 | $936,573 | $106,190 |
| 2021 | 17 | 1,086 | 1,177 | $686,032 | $122,813 |
| 2020 | 13 | 629 | 679 | $348,399 | $72,008 |
Total Patients
3,548
Total Services
3,819
Medicare Billing
$404,719
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 201 | 202 | $262,383 | $44,179 | 16.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 142 | 145 | $161,385 | $10,328 | 6.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 72 | 73 | $37,522 | $10,219 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 69 | $23,805 | $6,414 | 26.9% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 13 | 26 | $21,138 | $6,022 | 28.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 135 | 136 | $171,360 | $5,952 | 3.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 73 | $17,885 | $5,037 | 28.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 20 | 20 | $19,400 | $3,608 | 18.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 42 | $7,770 | $2,763 | 35.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $13,580 | $2,566 | 18.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $19,918 | $2,157 | 10.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $14,550 | $2,126 | 14.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 25 | 27 | $89,829 | $2,075 | 2.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 62 | 62 | $10,106 | $261.38 | 2.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 224 | 224 | $290,528 | $46,949 | 16.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 151 | 157 | $174,741 | $11,264 | 6.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 68 | 69 | $35,466 | $9,953 | 28.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 181 | 182 | $229,320 | $7,315 | 3.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 48 | $16,560 | $4,746 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 60 | $14,700 | $4,243 | 28.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 21 | 21 | $20,370 | $4,152 | 20.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 67 | $12,395 | $4,059 | 32.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 24 | 25 | $24,250 | $3,440 | 14.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $8,940 | $2,679 | 30.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 24 | $20,784 | $2,363 | 11.4% |
About Dr. Joshua Beirne, M.D
Dr. Joshua Beirne, M.D is a Internal Medicine healthcare provider based in Santa Rosa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841216041.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Beirne, M.D has received a total of $4,228 in payments from pharmaceutical and medical device companies, with $541.97 received in 2024. These payments were reported across 221 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,220).
As a Medicare-enrolled provider, Beirne has provided services to 3,548 Medicare beneficiaries, totaling 3,819 services with total Medicare billing of $404,719. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Santa Rosa, CA
- Active Since 07/14/2006
- Last Updated 10/15/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841216041
Products in Payments
- XIFAXAN (Drug) $373.61
- XELJANZ (Drug) $337.81
- STELARA (Biological) $314.48
- ENTYVIO (Biological) $262.96
- RINVOQ (Biological) $216.49
- LINZESS (Drug) $175.78
- Entyvio (Biological) $144.75
- SKYRIZI (Biological) $141.24
- Mavyret (Drug) $132.80
- Trulance (Drug) $107.62
- Creon (Drug) $102.03
- SUPREP (Drug) $96.39
- HUMIRA (Biological) $84.65
- Viekira (Drug) $80.30
- DUPIXENT (Biological) $74.75
- Humira (Biological) $72.11
- ZENPEP (Drug) $68.23
- OCALIVA (Drug) $66.97
- ZEPOSIA (Drug) $63.00
- REMICADE (Biological) $61.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Santa Rosa
Zeyad Kanaan, M.d, M.D
Internal Medicine — Payments: $230,599
Internal Medicine $230,599
Rajveer Sangera, Do, DO
Internal Medicine — Payments: $42,357
Internal Medicine $42,357
Pamela Maur, M.d, M.D
Internal Medicine — Payments: $41,731
Internal Medicine $41,731
Kent Matsuda, M.d, M.D
Internal Medicine — Payments: $9,102
Internal Medicine $9,102
Dr. Marlon Decastro, M.d, M.D
Internal Medicine — Payments: $7,445
Internal Medicine $7,445
Sara Keck, Md, MD
Internal Medicine — Payments: $7,051
Internal Medicine $7,051